Main > A1. CORP. INDEX. A-Am No. 1 > Alnylam/P C2

---

This data is not available for free

Alnylam/P C2's subsections
2003. 01.27.2003. (Focus)
2003. 02.12.2003. (IP In-Licencing)
2003. 04.28.2003. (Executive)
2003. 04.28.2003. (Merger)
2003. 07.07.2003. (Merger)
2003. 08.04.2003. (MIT Deal)
2003. 10.30.2003. (Parkinson d.)
2003. 12.11.2003. (Licensing Prog.)
2004. 09.06.2004. (AMD/Merck)
2004. 09.06.2004. (Executive)
2005. 03.29.2005. (DowPharma)
2005. 09.12.2005. (Novartis)
2005. 11.14.2005. (Antagomirs)
2006. 02.27.2006. (Novartis)
2006. 04.03.2006. VP Drug Discov.
2006. 07.06.2006. Merck USA
2006. 11.13.2006. Sr Director Bus.
2007. 01.09.2007. Inex Pharma.
2007. 07.16.2007. CEO
2007. 07.16.2007. Roche
2008. 03.03.2008. Patent in JP
2008. 03.20.2008. China
2008. 06.02.2008. Licensee>Asia
2009. 04.29.2009. Isis Pharma.
2009. 08.06.2009. Tekmira Pharma.
2010. 01.15.2010. German Patent
2010. 01.19.2010. Deliv.>Lipid Nano
2010. 04.07.2010. Patent Allowance
2010. 06.17.2010. IP>Vaccine R&D
2010. 06.17.2010. Patent Allowance
2010. 08.23.2010. Parkinsons Dis.
2010. 09.23.2010. Novartis
2010. 11.03.2010. Huntingtons Dis.
2010. 11.04.2010. Tekmira Pharma
2010. 12.02.2010. Patents
2011. 01.25.2011. TTR Amyloidosis
2011. 03.17.2011. Tekmira Pharma.
2011. 03.28.2011. Takeda Pharma.
2011. 04.07.2011. AlCana Tech.
2011. 04.19.2011. Precision Nano
2011. 06.13.2011. CMO
2011. 06.20.2011. Article in Nature
2011. 07.19.2011. MIT
2011. 11.01.2011. GSK
2011. 12.28.2011. Neuro.>Huntington
2012. 01.19.2012. ReStructuring
2012. 01.30.2012. Patent
2012. 04.20.2012. Cardio.>HyperChol
2012. 05.30.2012. Pneumo.>RSV
2012. 06.04.2012. Onco.>Liver C.
2012. 06.27.2012. Man. Team
2012. 07.12.2012. Onco.>Liver C.
2012. 07.13.2012. 2nd Gen. MC3 LNPs
2012. 08.28.2012. Monsanto
2013. 06.30. TTR Amyloidosis 02
2014. 01.12. Acq Sirna Therapeutics
2014. 01.13. Genzyme>Rare Dis.
2014. 03.26. Genzyme>Acq Co. Shares
2014. 05.13. Hemophilia & RBD
2014. 06.12. Hepato.>HBV>Patent
2014. 07.22. Patent
2014. 08.20. Patent
2014. 11.14. CV.>TTR Amyloidosis sc
2014. 12.12. Split in 3 Unis
2017. 09.20. Sanofi
2018. 03.21. Hepato.>NASH>Regeneron
2018. 08.10. hATTR USA>OK
2019. 04.08. Regeneron
2019. 06.18. hATTR JP>OK
2019. 11.20. Endo.>AHP>USA>OK
2020. 02.26. hATTR BR>OK
2020. 03.03. Endo..>AHP>EU>OK
2020. 11.19. Endo..>PH1>EU>OK
2020. 11.24. Endo..>PH1>USA>OK
2022. 06.13. hATTR USA>OK
2022. 09.20. hATTR EU>OK
Patent Applications
Web-Site

Alnylam/P C2's products
This section has no products